Auditory Stimulation for Schizophrenia
What You Need to Know Before You Apply
What is the purpose of this trial?
The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance under two conditions separated by one week: receiving auditory stimulation during sleep and not receiving auditory stimulation during sleep. The investigators will study healthy subjects and outpatients with schizophrenia.
Will I have to stop taking my current medications?
The trial does not specify if schizophrenia patients need to stop their current medications. However, healthy controls cannot be on psychotropic medications.
Is auditory stimulation therapy safe for humans?
How is auditory stimulation treatment different from other treatments for schizophrenia?
What data supports the effectiveness of the treatment Auditory Stimulation for Schizophrenia?
Who Is on the Research Team?
Dara Manoach, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for English-speaking men and women aged 18-50 who have been diagnosed with schizophrenia. Participants must be outpatients, meaning they aren't currently in the hospital, and able to give informed consent to participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo two conditions: receiving auditory stimulation during sleep and not receiving auditory stimulation, separated by one week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Auditory Stimulation
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor